OPKO HEALTH INC. - CO
1.6200
25-November-24 16:45:01
15 minutes delayed
Stocks
+0.0400
+2.53%
Today's range
1.5850 - 1.6500
ISIN
N/A
Source
NASDAQ
-
OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021
20 Jul 2021 08:00:02 By Nasdaq GlobeNewswire
-
OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics
12 Jul 2021 08:00:01 By Nasdaq GlobeNewswire
-
OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference
08 Jul 2021 16:05:00 By Nasdaq GlobeNewswire
-
OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx
22 Jun 2021 08:00:00 By Nasdaq GlobeNewswire
-
OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics
21 Jun 2021 08:03:07 By Nasdaq GlobeNewswire
-
OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland
17 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
OPKO Health to Participate in the Jefferies Virtual Healthcare Conference
27 May 2021 08:30:01 By Nasdaq GlobeNewswire
-
OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor
24 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders
07 May 2021 13:33:56 By Nasdaq GlobeNewswire
-
OPKO Health to Report First Quarter 2021 Financial Results on April 28, 2021
22 Apr 2021 08:00:01 By Nasdaq GlobeNewswire
-
OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
18 Feb 2021 16:05:01 By Nasdaq GlobeNewswire
-
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021
03 Feb 2021 09:01:22 By Nasdaq GlobeNewswire
-
28 Jan 2021 08:00:01 By Nasdaq GlobeNewswire
-
OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
05 Jan 2021 08:00:01 By Nasdaq GlobeNewswire